The PRAISE-MR study, recently presented at the ESC Heart Failure 2026 congress, evaluated the use of sacubitril/valsartan (ARNI) in patients with Heart Failure preserved ejection (HFpEF) and functional atrial mitral regurgitation (MR).
Closing out
🙏 for all comments
✅ Diagnosis: Acute AR, premature MV closure & diastolic MR. Others: fine diastolic fluttering of AML, systolic MR
✅ See⬇️ for more images. 1st clip shows AV veg
✅ 2nd image: MR on color- easy to confuse timing of MR with color only & cursory reading (watch out!)
✅ 3rd image: #1 diastolic MR, #2 systolic MR, #3 Early diastolic mitral flow
✅ 4th image: CW AR very rapid decel, end diastolic Vel 0, AR stops before diastole is over
Question: is this diastolic MR due to acute AR or long PR?
@argulian@KemalogluOz@dr_benoy_n_shah@iamritu@DavidWienerMD
The Canadian CV Society (CCS) guidelines 2025 have updated their recommendations on the use of Angiotensin II Receptor Antagonists (ARBs), integrating more therapeutic options for heart failure .Telmisartan irbesartan, and olmesartan are now accepted in clinical practice for (HF).
💡 Exploring latest rendering tools with new system Vivid Pioneer in patient with extensive P2 prolapse and P2-L flail.
Take a look to primary and secondary lesions with several anatomic details.
Un nuevo estudio dirigido por Sadeer Al-Kindi et al. Registrado en Texas desde 2016 hasta 2023 vinculó más de 42.000 casos de infarto de miocardio con cambios de temperatura a corto plazo.
Los hallazgos revelan un patrón de riesgo en forma de U: tanto los días más fríos como los moderadamente c��lidos aumentan el riesgo de infarto de miocardio.
Recordar la publicación Dr Kario y el frio HTA.
Excellent review of Heart failure HFrEF
Optimal treat include the initiation and rapid titration of 4 key drug (RAS-i or ARNI, b-blockers, angiotensin II receptor antagonists, SGLT2 inhibitors), along with diuretics to relieve congestion. Finerenone and vericiguat may be appropriate.
STENO 2 TRIAL emblematic study benefits of a multifactorial and intensive approach in patients with type 2 diabetes and microalbuminuria. After an extended follow-up of 21.2 years.
Some analyses estimating that up to 70% of the total CV risk reduction study was lipid intervention.
Steno-2 is a landmark clinical trial that demonstrated the benefits of a multifactorial and intensive approach in patients with type 2 diabetes and microalbuminuria.
4D Echo Course https://t.co/jLJAl1NU3y by @GEHealthCare
Led by : @lpbadano@AHagendorff and Jaroslaw Kasprzak.
🫀 4D Echocardiography Course
📍 Budapest | Nov 23–25, 2025
👥 Max 40 | 💶 €350 members
Hands-on EchoPAC™ training!
#4DEcho
Register now: https://t.co/eouMWk6lzk
Athlete's Heart (Syndrome) refers to physiological cardiac changes that occur as a result of the hemodynamic stress of regular strenuous exercise.
Watch our video, "HCM versus Athlete's Heart," from our Microlesson Series on HCM! https://t.co/e8XH6luFOV #HCM
Twitter, entre sus múltiples penurias, tiene la increíble capacidad de traerte cosas que nunca has visto e integrarlas con absoluta naturalidad. Y aprender
Esto es una salvajada de danza carotídea de Corrigan en un paciente con una IAO épica
Maravillosa y a la vez terrible
Pure bliss from a master @LHoyesWouter 🌟🌟Thank you for sharing your knowledge and giving us a valuable and detailed insight on how to improve our skills in 4D echo🙏🙏 @VerwerftJan@HartcentrumH#echofirst
This is an ACC infographic for Heart Failure With Preserved Ejection Fraction (HFpEF) to raise awareness about subtypes and comorbidities of this syndrome, and therapeutic approaches.
Don't let the heart failure light go out .Don't let the heart failure light go out .
Don't let the heart failure light go out .💡💡🔦🎻